Elpiscience (suzhou) Biopharma, Ltd.

This study tests a new drug (ES102) combined with an immunotherapy (toripalimab) in 40 people with advanced non-small cell lung cancer that has not responded to prior treatments. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must …

This study tests an experimental drug called ES014 in 50 adults with desmoid tumors, a type of non-cancerous but often painful growth. The goal is to see if the drug can shrink or control the tumors and improve symptoms. Participants must have tumors that are growing or causing p…